Reduces the frequency of systemic fungal infections . . .
• Broad spectrum triazole antifungal activity
• Histoplasmosis and blastomycosis without central nervous system involvement
• Reduces the frequency of systemic fungal infections
• Offers advantage of broad antifungal spectrum and better effectiveness in onychomycosis
compared to terbinafine
| Country of Origin | Made in India |
| Shelf Life | 2 years |
| Manufacturer | Mecoson pharma |
| Brand | Itramec |
| Packaging Size | 10*10 Blister |
| Deals in | PCD Pharma,Third Party Manufacturing |